Clinical Trials Logo

Antipsychotics Weight Gain clinical trials

View clinical trials related to Antipsychotics Weight Gain.

Filter by:
  • None
  • Page 1

NCT ID: NCT02949752 Completed - Clinical trials for Antipsychotics Weight Gain

Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile

Start date: August 2016
Phase: Phase 4
Study type: Interventional

This is an open label study to prospectively evaluate the effect of adjunct use of Aripiprazole, as an agent to improve metabolic profile and induce weight loss in patients established on atypical antipsychotics (Olanzapine, Clozapine and Risperidone).